期刊文献+

纳米炭混悬液在乳腺癌前哨淋巴结活检中的应用分析 被引量:2

Application analysis of carbon nanoparticles suspension in sentinel lymph node biopsy for breast cancer
下载PDF
导出
摘要 目的研究纳米炭混悬液(卡纳琳)在乳腺癌前哨淋巴结活检(sentinel lymph nodebiopsy,SLNB)中的应用价值。方法回顾性分析我院乳腺外科收治的124例乳腺癌患者的临床资料,将其中100例乳腺癌患者随机分成2组,实验组50例,以纳米炭混悬液作为示踪剂;对照组50例,以放射性核素联合美蓝作为示踪剂。全部患者SLNB后常规行腋窝淋巴结清扫术(axillary lymph node dissection,ALND)。术后检验其检出率、准确率、灵敏度、假阴性率。另24例患者以纳米炭混悬液示踪行SLNB后,如前哨淋巴结(SLN)阳性,则继续行ALND;如SLN阴性,则“保腋窝”。根据患者选择术式的不同对比其手术效果及预后。结果实验组与对照组患者前哨淋巴结检出率、准确率、灵敏度、假阴性率比较,差异无统计学意义(P〉0.05)。结论纳米炭混悬液示踪SLNB可准确预测早期乳腺癌患者的淋巴结状态,较行ALND患者有更少的并发症。 [ Abstract ] Objective To evaluate the application values of carbon nanoparticles suspension in sentinel lymph node biopsy (SLNB)for breast cancer. Methods The clinical data of 124 breast cancer patients were retrospectively reviewed. One hundred cases of them were randomly divided into two groups, including 50 patients with carbon nanoparticles suspension injection before the operation and 50 patients with radionuclide combined with methylene blue as the tracer. All the patients received axillary lymph node dissection(ALND) after SLNB. The detection rate, accuracy, sensitivity ,false negative rate were test- ed postoperatively. The rest 24 patients received carbon nanoparticles suspension in SLNB. If the sentinel lymph node (SLN)was positive, the patient received ALND;if the SLN was negative, the surgery would be terminated. The surgical effects and prognosis were compared depending on the choice of different surgical procedures. Results The difference of the sentinel lymph node detection rate, accuracy, sensitivity and false negative rate were significant ( P 〉 0.05 ) between the two groups. Conclusion For patients with ear- ly breast cancer, tracing SLNB with carbon nanoparticles suspension can accurately predict the lymph node status and reduce complications.
出处 《临床外科杂志》 2015年第7期511-513,共3页 Journal of Clinical Surgery
关键词 前哨淋巴结 纳米炭混悬液 乳腺癌 并发症 sentinel lymph node carbon nanoparticles suspension breast cancer complications
  • 相关文献

参考文献4

二级参考文献38

  • 1龙飞,张斌,李爽.乳腺癌新辅助化疗后前哨淋巴结活检术的研究[J].中国实用外科杂志,2006,26(4):275-276. 被引量:18
  • 2Chua B,Ung O,Taylor R,et al.Frequency and predictors of axillary lymph node metastases in invasive breast cancer.ANZ J Surg,2001,71:723-728.
  • 3Cunnick GH,Jiang WG,Gomez KF,et al.Lymphangiogenesis and breast cancer metastasis.Histol Histopathol,2002,17:863-870.
  • 4Early Breast Cancer Trialists' Collaborative Group (EBCTCG).Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:an overview of the randomised trials.Lancet,2005,366,2087-2106.
  • 5Kim T,Giuliano AE,Lyman GH.Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma:a meta analysis.Cancer,2006,106:4-16.
  • 6Lyman GH,Giuliano AE,Somerfield MR,et al.American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.J Clin Oncol,2005,23:7703-7720.
  • 7Veronesi U,Paganelli G,Viale G,et al.Sentinel lymph node biopsy as a staging procedure in breast cancer:update of a randomized controlled study.Lancet Oncol,2007,7:983-989.
  • 8Fiorito S,Serafino A,Andreola F,et al.Toxicity and biocompatibility of carbon nanoparticles.J Nanosci Nanotechnol,2006,6:591-599.
  • 9Yokota T,Saito T,Narushima Y,et al.Lymph-node staining with activated carbon CH40:a new method for axillary lymph-node dissection in breast cancer.Can J Surg,2000,43:191-196.
  • 10Tongeren MJ,Kromhout H,Gardiner K.Trends in levels of inhalable dust exposure,exceedance and overexposure in the European carbon black manufacturing industry.Ann Occup Hyg,2000,44:271-280.

共引文献104

同被引文献32

  • 1Szyc L, Bonifer S, Waiter A, et al. Devel- opment of a handheld fluorescence ima- ging camera for intraoperative sentinel lymph node mapping[ J]. J Biomed Opt, 2015,20(5) :2-12.
  • 2Samorani D, Fogacci T, Panzini I, et al. The u of indocyanine green to detect sentinel nodes in breast cancer: A pro- spective study [ J ]. Eur J Surg Oncol, 2015,41 ( 1 ) :64-70.
  • 3Hirche C, Murawa D, Mohr Z, et al. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer [J]. Breast Cancer Res Treat,2010,121 (2) :373-378.
  • 4Murawa D, Hirche C, Dresel S,et al. Sen- tinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence [ J ]. Br J Surg, 2009, 96 ( 11 ) : 1289- 1294.
  • 5Sugie T, Sawada T, Tagaya N, et al. Com- parison of the indocyanine green fluores- cence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer[ J]. Ann Surg Oncol,2013, 20(7) :2213-2218.
  • 6Gherghe M, Bordea C, Blidaru A. Sentinel lymph node biopsy ( SLNB ) vs. axillary lymph node dissection (ALND) in the cur- rent surgical treatment of early stage breastcancer[J]. J Med Life,2015,8(2) :176- 180.
  • 7Toh U, Iwakuma N, Mishima M, et al. Nav- igation surgery for intraoperative sentinel lymph node detection using Indocyanine green(ICG) fluorescence real-time imaging in breast cancer [ J ]. Breast Cancer Res treat ,2015,153 ( 2 ) : 337-344.
  • 8Ballardini B, Santoro L, Sangalli C, et al. The indocyanine green method is equiva- lent to the 99Tc-labeled radiotracer meth- od for identifying the sentinel node in breast cancer:A concordance and valida- tion study[J]. Eur J Surg Onco,2013,39 (12) :1332-1336.
  • 9Hirano A, Kamimura M, Ogura K, et al. A comparison of indoeyanine green fluores- cence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients [ J ]. Ann Surg Oncol,2012,19 (13) :4112-4116.
  • 10van der Vorst JR,Scbaafsma BE, Verbeek FP, et al. Randomized comparison of near- infrared fluorescence imaging using indo- cyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer pa- tients [ J ]. Ann Surg 0neol, 2012, 19 (13) :4104-4111.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部